Free Trial
ASX:SNT

Syntara (SNT) Stock Price, News & Analysis

Syntara logo

About Syntara Stock (ASX:SNT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Syntara Limited operates as a clinical stage drug development company that focuses on blood-related cancers. Its lead product candidate is PXS-5505, which is in phase 2 trial for the bone marrow cancer myelofibrosis, which causes a build-up of scar tissue leading to loss of red and white blood cells and platelets. The company was formerly known as Pharmaxis Ltd and changed its name to Syntara Limited in December 2023. Syntara Limited was incorporated in 1998 and is headquartered in Frenchs Forest, Australia.

Receive SNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Syntara and its competitors with MarketBeat's FREE daily newsletter.

SNT Stock News Headlines

Grab This Altcoin Before Trump's Crypto Announcement
Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.
Syntara Limited to Issue 250 Million Shares
Syntara Limited Announces New Securities Issue Plan
See More Headlines

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Electronic Equipment
CIK
N/A
Fax
N/A
Employees
160
Year Founded
N/A

Profitability

Net Income
$-13,670,000.00
Net Margins
-262.70%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.76 million

Miscellaneous

Outstanding Shares
1,370,000,000
Free Float
N/A
Optionable
N/A
Beta
0.62
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (ASX:SNT) was last updated on 2/23/2025 by MarketBeat.com Staff
From Our Partners